427 related articles for article (PubMed ID: 23052193)
1. Risk assessment of nanomaterials in cosmetics: a European union perspective.
Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
[TBL] [Abstract][Full Text] [Related]
2. In the shadow of the Cosmetic Directive--inconsistencies in EU environmental hazard classification requirements for UV-filters.
Sobek A; Bejgarn S; Rudén C; Molander L; Breitholtz M
Sci Total Environ; 2013 Sep; 461-462():706-11. PubMed ID: 23770551
[TBL] [Abstract][Full Text] [Related]
3. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
[TBL] [Abstract][Full Text] [Related]
4. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
;
Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
[TBL] [Abstract][Full Text] [Related]
5. The changes in hazard classification and product notification procedures of the new European CLP and Cosmetics Regulations.
de Groot R; Brekelmans P; Herremans J; Meulenbelt J
Clin Toxicol (Phila); 2010 Jan; 48(1):28-33. PubMed ID: 20055632
[TBL] [Abstract][Full Text] [Related]
6. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
Vinardell MP
Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
[TBL] [Abstract][Full Text] [Related]
7. Continuing animal tests on cosmetic ingredients for REACH in the EU.
Knight J; Rovida C; Kreiling R; Zhu C; Knudsen M; Hartung T
ALTEX; 2021; 38(4):653-668. PubMed ID: 34402521
[TBL] [Abstract][Full Text] [Related]
8. EU legislations affecting safety data availability of cosmetic ingredients.
Pauwels M; Rogiers V
Regul Toxicol Pharmacol; 2007 Dec; 49(3):308-15. PubMed ID: 17919792
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
10. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
[TBL] [Abstract][Full Text] [Related]
11. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment of personal care products/cosmetics and their ingredients.
Nohynek GJ; Antignac E; Re T; Toutain H
Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for safety evaluation of cosmetics ingredients in the EC countries.
Loprieno N
Food Chem Toxicol; 1992 Sep; 30(9):809-15. PubMed ID: 1427520
[TBL] [Abstract][Full Text] [Related]
14. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
Daly P; Moran G
Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
[TBL] [Abstract][Full Text] [Related]
15. Principle considerations for the risk assessment of sprayed consumer products.
Steiling W; Bascompta M; Carthew P; Catalano G; Corea N; D'Haese A; Jackson P; Kromidas L; Meurice P; Rothe H; Singal M
Toxicol Lett; 2014 May; 227(1):41-9. PubMed ID: 24657525
[TBL] [Abstract][Full Text] [Related]
16. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
Pauwels M; Rogiers V
Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
[TBL] [Abstract][Full Text] [Related]
18. [Expected change of direction in Polish law regarding cosmetics].
Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
[TBL] [Abstract][Full Text] [Related]
19. The hazard communication of fragrance allergens must be improved.
Klaschka U
Integr Environ Assess Manag; 2013 Jul; 9(3):358-62. PubMed ID: 23325757
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of toxicological evaluations for dermal exposure performed under two different EU regulatory frameworks.
Westerholm E; Schenk L
Regul Toxicol Pharmacol; 2014 Feb; 68(1):51-8. PubMed ID: 24269627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
